Recommendation of the President – K.Vita
On 17 October 2025, the President of the Agency for Health Technology Assessment and Tariff System issued recommendation No. 149/2025 on the validity of issuing approvals for the reimbursement of the foodstuff for special nutritional purposes K.Vita in the following indications: drug-resistant epilepsy, LCHAD deficiency, VLCAD deficiency, pyruvate dehydrogenase deficiency, GLUT1 deficiency